BIIB34 fundamentals
An in-depth look to BIOGEN DRN operating, investing, and financing activities
BIIB34 free cash flow for Q1 24 is 2.51 B BRL. For 2023, BIIB34 free cash flow was -28.25 B BRL and operating cash flow was 7.73 B BRL.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: BRL
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM